Profil
Mark E.
Platt is currently the President, Chief Executive Officer & Director at Makana Therapeutics, Inc. Prior to his current position, he served as the Chief Executive Officer at Recombinetics, Inc. from 2019 to 2021.
Mark also held the position of President & Chief Executive Officer at Multistack LLC from 1995 to 2013.
He obtained his undergraduate degree from Vanderbilt University.
Aktiva positioner av Mark E. Platt
| Företag | Position | Start |
|---|---|---|
Makana Therapeutics, Inc.
Makana Therapeutics, Inc. BiotechnologyHealth Technology Develops swine transplantation of cells, tissues and organs from animals | Verkställande Direktör | - |
Tidigare kända positioner av Mark E. Platt
| Företag | Position | Slut |
|---|---|---|
Recombinetics, Inc.
Recombinetics, Inc. BiotechnologyHealth Technology Develops therapeutic applications for gene editing | Verkställande Direktör | 2021-01-18 |
Multistack LLC
Multistack LLC Industrial MachineryProducer Manufacturing Manufactures and distributes chillers and cooling products | Verkställande Direktör | 2013-10-01 |
Mark E. Platts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Recombinetics, Inc.
Recombinetics, Inc. BiotechnologyHealth Technology Develops therapeutic applications for gene editing | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Multistack LLC
Multistack LLC Industrial MachineryProducer Manufacturing Manufactures and distributes chillers and cooling products | Producer Manufacturing |
Makana Therapeutics, Inc.
Makana Therapeutics, Inc. BiotechnologyHealth Technology Develops swine transplantation of cells, tissues and organs from animals | Health Technology |
















